<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02922647</url>
  </required_header>
  <id_info>
    <org_study_id>38RC14.457</org_study_id>
    <nct_id>NCT02922647</nct_id>
  </id_info>
  <brief_title>Suprapubic Versus Transurethral Catheterization After Rectal Resection With Low Anastomosis for Cancer in Males</brief_title>
  <acronym>GRECCAR10</acronym>
  <official_title>Suprapubic Versus Transurethral Catheterization After Rectal Resection With Low Anastomosis for Cancer in Males</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The urpose of this study is to compare the urinary tract infection rate on the four
      postoperative day between the 2 groups of patients who have undergone total mesorectal
      excision for cancer and low anastomosis, with either suprapubic or transurethral
      catheterization.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with urinary tract infection when using suprapubic versus transurethral catheterization as assessed by significant bacteriuria and pyuria</measure>
    <time_frame>four days postoperative</time_frame>
    <description>The urinary tract infection, defined as significant bacteriuria ( &gt; 104 CFU / mL) and pyuria (&gt; 6 white blood cells per high power field) in urine samples obtained immediately after removal of the urethral catheter or clamping suprapubic catheter and removing the fourth postoperative day.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of catherism as assessed by the number of days for participants with the catheter and number of participants leaving the hospital with the catheter</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain as assessed by visual analogue scale (0 to 10 score) for abdomen and urethra</measure>
    <time_frame>at 1, 2, 3 and 4 days</time_frame>
    <description>visual analogue scale (0-10) for both the abdomen and the urethra (a measure daily until hospital discharge )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants morbidity and mortality as assessed by Dindo and Clavien classification</measure>
    <time_frame>at 1 month and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of satisfaction for participants as assessed by questionnaries (Fact-C and EQ-5D-3L</measure>
    <time_frame>at 30 days and 6 months</time_frame>
    <description>Patient satisfaction : very, or moderately dissatisfied , unchanged , slightly , moderately , or very disappointed at the exit of the Fact- C hospital and EQ-5D - 3L at 30 days and 6 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost as assessed by the addition of the costs of the full process depending on the catheterism duration and additional consultations and readmissions for complications</measure>
    <time_frame>at 6 months</time_frame>
    <description>Estimated cost of complications, urologic surgery, medication , hospitalization, additional consultations and readmissions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay in days</measure>
    <time_frame>within 6 months</time_frame>
    <description>the hospital stay by day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of recatheterization</measure>
    <time_frame>in the first 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of postoperative return to normal bladder function as assessed by IPSS score</measure>
    <time_frame>at 1 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of additionnal consultations</measure>
    <time_frame>in the first 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lack of comfort as assessed by visual analogue scale (0 to 10 score) for abdomen and urethra</measure>
    <time_frame>at 1, 2, 3 and 4 days</time_frame>
    <description>visual analogue scale (0-10) for both the abdomen and the urethra (a measure daily until hospital discharge )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific complications</measure>
    <time_frame>in the first 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Infection</condition>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>suprapubic catheterization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention:suprapubic catheterization after rectal resection with low anastomosis. Evaluate the urinary tract infection rate on the four days postoperative.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>transurethral catheterization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention:transurethral catheterization after rectal resection with low anastomosis. Evaluate the urinary tract infection rate on the four days postoperative.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>suprapubic catheterization</intervention_name>
    <description>Experimental Arm: Suprapubic catheterization after rectal resection with low anastomosis for cancer in males</description>
    <arm_group_label>suprapubic catheterization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transurethral catheterization</intervention_name>
    <description>Active comparator: Transurethral catheterization after rectal resection with low anastomosis for cancer in males</description>
    <arm_group_label>transurethral catheterization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male patients of at least 18 years of age

          -  Histologically proven rectal adenocarcinoma

          -  Stage T1-4 Nx Mx

          -  With or without neoadjuvant treatment

          -  TME and low anastomosis (colorectal or coloanal, stapled or handsewn)

          -  With or without loop ileostomy

          -  Open or laparoscopic approach

          -  Patient and doctor have signed a study specific informed consent form

        Exclusion Criteria:

          -  Colonic and upper third rectal cancer (No or Partial Mesorectal Excision)

          -  Abdominoperineal resection

          -  Associated prostate, and/or seminal glands and/or bladder resection

          -  Infected tumour, Emergency surgery

          -  Epidural analgesia

          -  Patient with antibiotic therapy (other than prophylaxis)

          -  Previous treated/untreated known prostate or bladder carcinoma

          -  Patient with symptomatic preoperative voiding dysfunction (IPSS score &gt;19)

          -  Medical history of bladder catheterization for obstruction, or urethral surgery

          -  Patient necessitating urinary output monitoring (impaired renal function etc)

          -  Patient deprived of liberty or under guardianship or incapable of giving consent

          -  Against the usual indications of suprapubic drainage and / or urethral sounding any
             known allergies to medical device materials. (p. ex. latex) and in general the known
             allergies to sterilizing agents (particularly oxide ethylene and its derivatives.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pr Jean Luc FAUCHERON</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Clinic of Digestive Surgery and Emergency</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fatah TIDADINI</last_name>
    <phone>04 76 76 70 79</phone>
    <email>FTidadini@chu-grenoble.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Grenoble</name>
      <address>
        <city>Grenoble,</city>
        <state>Rhone alpes</state>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pr Jean Luc FAUCHERON, Phd</last_name>
      <phone>04 76 76 53 71</phone>
      <email>JLFaucheron@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Fatah TIDADINI</last_name>
      <phone>04 76 76 70 79</phone>
      <email>FTidadini@chu-grenoble.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Shah EF, Huddy SP. A prospective study of genito-urinary dysfunction after surgery for colorectal cancer. Colorectal Dis. 2001 Mar;3(2):122-5.</citation>
    <PMID>12791005</PMID>
  </reference>
  <reference>
    <citation>Sterk P, Shekarriz B, Günter S, Nolde J, Keller R, Bruch HP, Shekarriz H. Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision: prospective study on 52 patients. Int J Colorectal Dis. 2005 Sep;20(5):423-7. Epub 2005 Apr 22.</citation>
    <PMID>15846498</PMID>
  </reference>
  <reference>
    <citation>Branagan GW, Moran BJ. Published evidence favors the use of suprapubic catheters in pelvic colorectal surgery. Dis Colon Rectum. 2002 Aug;45(8):1104-8.</citation>
    <PMID>12195198</PMID>
  </reference>
  <reference>
    <citation>Lee SY, Kang SB, Kim DW, Oh HK, Ihn MH. Risk factors and preventive measures for acute urinary retention after rectal cancer surgery. World J Surg. 2015 Jan;39(1):275-82. doi: 10.1007/s00268-014-2767-9.</citation>
    <PMID>25189452</PMID>
  </reference>
  <reference>
    <citation>Platt R, Polk BF, Murdock B, Rosner B. Mortality associated with nosocomial urinary-tract infection. N Engl J Med. 1982 Sep 9;307(11):637-42.</citation>
    <PMID>7110215</PMID>
  </reference>
  <reference>
    <citation>Tambyah PA, Oon J. Catheter-associated urinary tract infection. Curr Opin Infect Dis. 2012 Aug;25(4):365-70. doi: 10.1097/QCO.0b013e32835565cc. Review.</citation>
    <PMID>22691687</PMID>
  </reference>
  <reference>
    <citation>Rasmussen OV, Korner B, Møller-Sørensen P, Kronborg O. Suprapubic versus urethral bladder drainage following surgery for rectal cancer. Acta Chir Scand. 1977;143(6):371-4.</citation>
    <PMID>605738</PMID>
  </reference>
  <reference>
    <citation>Shapiro J, Hoffmann J, Jersky J. A comparison of suprapubic and transurethral drainage for postoperative urinary retention in general surgical patients. Acta Chir Scand. 1982;148(4):323-7.</citation>
    <PMID>7136436</PMID>
  </reference>
  <reference>
    <citation>Sethia KK, Selkon JB, Berry AR, Turner CM, Kettlewell MG, Gough MH. Prospective randomized controlled trial of urethral versus suprapubic catheterization. Br J Surg. 1987 Jul;74(7):624-5.</citation>
    <PMID>3304522</PMID>
  </reference>
  <reference>
    <citation>Piergiovanni M, Tschantz P. [Urinary catheterization: transurethral or suprapubic approach?]. Helv Chir Acta. 1991 Jul;58(1-2):201-5. French.</citation>
    <PMID>1938446</PMID>
  </reference>
  <reference>
    <citation>O'Kelly TJ, Mathew A, Ross S, Munro A. Optimum method for urinary drainage in major abdominal surgery: a prospective randomized trial of suprapubic versus urethral catheterization. Br J Surg. 1995 Oct;82(10):1367-8.</citation>
    <PMID>7489167</PMID>
  </reference>
  <reference>
    <citation>Ratnaval CD, Renwick P, Farouk R, Monson JR, Lee PW. Suprapubic versus transurethral catheterisation of males undergoing pelvic colorectal surgery. Int J Colorectal Dis. 1996;11(4):177-9.</citation>
    <PMID>8876274</PMID>
  </reference>
  <reference>
    <citation>Perrin LC, Penfold C, McLeish A. A prospective randomized controlled trial comparing suprapubic with urethral catheterization in rectal surgery. Aust N Z J Surg. 1997 Aug;67(8):554-6.</citation>
    <PMID>9287924</PMID>
  </reference>
  <reference>
    <citation>Baan AH, Vermeulen H, van der Meulen J, Bossuyt P, Olszyna D, Gouma DJ. The effect of suprapubic catheterization versus transurethral catheterization after abdominal surgery on urinary tract infection: a randomized controlled trial. Dig Surg. 2003;20(4):290-5. Epub 2003 Jun 5.</citation>
    <PMID>12789024</PMID>
  </reference>
  <reference>
    <citation>McPhail MJ, Abu-Hilal M, Johnson CD. A meta-analysis comparing suprapubic and transurethral catheterization for bladder drainage after abdominal surgery. Br J Surg. 2006 Sep;93(9):1038-44. Review.</citation>
    <PMID>16804872</PMID>
  </reference>
  <reference>
    <citation>Niël-Weise BS, van den Broek PJ. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004203. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD004203.</citation>
    <PMID>16034924</PMID>
  </reference>
  <reference>
    <citation>Healy EF, Walsh CA, Cotter AM, Walsh SR. Suprapubic compared with transurethral bladder catheterization for gynecologic surgery: a systematic review and meta-analysis. Obstet Gynecol. 2012 Sep;120(3):678-87. doi: 10.1097/AOG.0b013e3182657f0d. Review.</citation>
    <PMID>22914481</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2016</study_first_submitted>
  <study_first_submitted_qc>October 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2016</study_first_posted>
  <last_update_submitted>January 17, 2017</last_update_submitted>
  <last_update_submitted_qc>January 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

